Table 1.

Raw electrophysiological data

GenotypeConditionmEPSP (mV)mEPSP noise (µV)mEPSP/noise ratiomEPSP frequency (Hz)EPSP (mV)QCIR (MΩ)RMP (mV)nFigure
w1118 (WT)25°C0.85 ± 0.0416.5 ± 1.857.3 ± 5.73.5 ± 0.332.0 ± 1.238.5 ± 1.76.4 ± 0.6–64.6 ± 1.1131, 2
w;; MHC-Gal4/+25°C0.65 ± 0.0323.3 ± 1.228.2 ± 1.34.3 ± 0.533.6 ± 1.852.1 ± 1.84.8 ± 0.2–66.1 ± 1.2131, 2
UAS-GluRIIAM614R/+; MHC-Gal4/+25°C0.44 ± 0.0213.8 ± 0.532.2 ± 1.70.6 ± 0.135.0 ± 1.880.3 ± 4.15.8 ± 0.5–69.1 ± 1.2111, 2
w111829°C0.72 ± 0.0316.7 ± 0.743.6 ± 2.21.8 ± 0.232.9 ± 1.246.4 ± 2.26.2 ± 0.5–64.4 ± 0.9141, 2
w;; MHC-Gal4/+29°C0.52 ± 0.0221.8 ± 0.724.1 ± 1.02.4 ± 0.131.7 ± 1.361.2 ± 2.45.3 ± 0.4–66.5 ± 1.0121, 2
UAS-GluRIIAM614R/+; MHC-Gal4/+29°C0.35 ± 0.0213.8 ± 0.926.4 ± 2.30.2 ± 0.023.3 ± 1.268.9 ± 5.75.2 ± 0.2–65.0 ± 1.1101, 2
UAS-GluRIIAM614R/+; MHC-Gal4/Gal80TSEarly third instar; 25°C1.27 ± 0.126.6 ± 3.153.4 ± 7.32.0 ± 0.333.2 ± 2.127.4 ± 2.49.5 ± 0.8–64.7 ± 2.0103
UAS-GluRIIAM614R/+; MHC-Gal4/Gal80TSEarly third instar; 29°C0.60 ± 0.0518.7 ± 1.932.8 ± 1.20.4 ± 0.125.1 ± 1.443.1 ± 2.613.6 ± 0.9–63.0 ± 0.8103
UAS-GluRIIAM614R/+; MHC-Gal4/Gal80TS21°C0.83 ± 0.035.1 ± 0.533.3 ± 1.940.7 ± 2.45.6 ± 0.4–66.3 ± 0.8144, 5
UAS-GluRIIAM614R/+; MHC-Gal4/Gal80TS29°C0.42 ± 0.020.4 ± 0.125.6 ± 2.162.5 ± 4.86.0 ± 0.3–66.8 ± 1.1154, 5
UAS-GluRIIAM614R/+; MHC-Gal4/Gal80TS1-d recovery at 21°C0.39 ± 0.020.6 ± 0.124.1 ± 1.463.1 ± 5.05.3 ± 0.3–66.0 ± 1.194, 5
UAS-GluRIIAM614R/+; MHC-Gal4/Gal80TS2-d recovery at 21°C0.69 ± 0.023.4 ± 0.337.8 ± 1.255.4 ± 1.95.3 ± 0.3–67.7 ± 0.7104, 5
UAS-GluRIIAM614R/+; MHC-Gal4/Gal80TS3-d recovery at 21°C0.80 ± 0.045.6 ± 0.435.3 ± 1.544.7 ± 1.75.5 ± 0.2–68.4 ± 0.9114, 5
UAS-GluRIIAM614R/+; BG57-Gal4/Gal80TS25°C0.79 ± 0.042.4 ± 0.731.1 ± 1.639.5 ± 1.95.3 ± 0.4–68.4 ± 1.1136
UAS-GluRIIAM614R/+; BG57-Gal4/Gal80TS28.5°C0.62 ± 0.050.6 ± 0.131.5 ± 1.353.6 ± 3.67.2 ± 0.4–67.0 ± 1.3136
UAS-GluRIIAM614R/+; BG57-Gal4/Gal80TS2-d recovery at 25°C0.79 ± 0.031.4 ± 0.231.3 ± 1.439.9 ± 1.86.3 ± 0.3–66.7 ± 1.1146
w111830°C0.78 ± 0.042.4 ± 0.233.1 ± 1.442.9 ± 1.96.8 ± 0.3–66.2 ± 0.8157
w; GluRIIASP1630°C0.32 ± 0.020.8 ± 0.121.9 ± 2.267.4 ± 6.86.0 ± 0.4–63.0 ± 0.5157
MHC-Gal4/+30°C0.47 ± 0.021.1 ± 0.128.9 ± 0.664.3 ± 3.64.9 ± 0.2–63.9 ± 0.9157
UAS-GluRIIAM614R/+; MHC-Gal4/+30°C0.33 ± 0.010.2 ± 0.015.4 ± 1.147.0 ± 2.85.3 ± 0.2–64.4 ± 0.9137
w;; BG57-Gal4/+30°C0.51 ± 0.030.6 ± 0.131.3 ± 1.463.9 ± 4.56.6 ± 0.3–70.2 ± 1.4127
UAS-GluRIIAM614R/+; BG57-Gal4/+30°C0.35 ± 0.030.8 ± 0.713.5 ± 1.339.1 ± 3.46.1 ± 0.5–65.5 ± 1.697
w111831°C0.71 ± 0.032.4 ± 0.236.9 ± 1.653.6 ± 3.02.0 ± 0.2–68.1 ± 1.5147
w; GluRIIASP1631°C0.36 ± 0.021.1 ± 0.225.8 ± 1.574.4 ± 5.44.2 ± 0.9–66.6 ± 1.3137
w111832°C0.47 ± 0.012.4 ± 1.130.7 ± 1.964.8 ± 4.12.0 ± 0.4–63.7 ± 0.9137
w; GluRIIASP1632°C0.37 ± 0.031.4 ± 0.921.0 ± 2.256.1 ± 4.45.6 ± 0.3–65.0 ± 0.8107
  • Full genotypes and rearing conditions for electrophysiological data presented in the study. Average values ± SEM are presented for each parameter; n, number of NMJs recorded. Values include mEPSP amplitude, noise, amplitude to noise ratio, and frequency; EPSP amplitude; quantal content (QC); muscle input resistance (IR); and resting membrane potential (RMP).